Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction;
Allen, JK, Armaiz-Pena, GN, Nagaraja, AS, Sadaoui, NC, Ortiz, T, Dood, R, Ozcan, M, Herder, DM, Haemmerle, M, Gharpure, KM, Rupaimoole, R, Previs, RA, Wu, SY, Pradeep, S, Xu, X, Han, HD, Zand, B, Dalton, HJ, Taylor, M, Hu, W, Bottsford-Miller, J, Moreno-Smith, M, Kang, Y, Mangala, LS, Rodriguez-Aguayo, C, Sehgal, V, Spaeth, EL, Ram, PT, Wong, STC, Marini, FC, Lopez-Berestein, G, Cole, SW, Lutgendorf, SK, De Biasi, M & Sood, AK 2018, Cancer Research, vol. 78, no. 12, pp. 3233-3242. DOI: 10.1158/0008-5472.CAN-16-1701c

Two birds, one stone: Hesperetin alleviates chemotherapyinduced diarrhea and potentiates tumor inhibition;
Yu, Y, Kong, R, Cao, H, Yin, Z, Liu, J, Nan, X, Phan, AT, Ding, T, Zhao, H & Wong, STC 2018, Oncotarget, vol. 9, no. 46, pp. 27958-27973. DOI: 10.18632/oncotarget.24563

Is pathology prepared for the adoption of artificial intelligence?;
Wong, STC 2018, Cancer Cytopathology, vol. 126, no. 6, pp. 373-375. DOI: 10.1002/cncy.21994

Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer;
Yeung, T-L, Sheng, J, Leung, CS, Li, F, Kim, J, Ho, SY, Matzuk, MM, Lu, KH, Wong, STC & Mok, SC 2018, Journal of the National Cancer Institute. DOI: 10.1093/jnci/djy097

Targeting brain-adaptive cancer stem cells prohibits brain metastatic colonization of triple-negative breast cancer;
Ren, D, Zhu, X, Kong, R, Zhao, Z, Sheng, J, Wang, J, Xu, X, Liu, J, Cui, K, Zhang, XHF, Zhao, H & Wong, STC 2018, Cancer Research, vol. 78, no. 8, pp. 2052-2064. DOI: 10.1158/0008-5472.CAN-17-2994

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance;
Leung, CS, Yeung, TL, Yip, KP, Wong, KK, Ho, SY, Mangala, LS, Sood, AK, Lopez-Berestein, G, Sheng, J, Wong, STC, Birrer, MJ & Mok, SC 2018, Journal of Clinical Investigation, vol. 128, no. 2, pp. 589-606. DOI: 10.1172/JCI95200

The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability;
Wang, H, Tian, L, Liu, J, Goldstein, A, Bado, I, Zhang, W, Arenkiel, BR, Li, Z, Yang, M, Du, S, Zhao, H, Rowley, DR, Wong, STC, Gugala, Z & Zhang, XHF 2018, Cancer Cell. DOI: 10.1016/j.ccell.2018.10.002

KAT2A coupled with the a-KGDH complex acts as a histone H3 succinyltransferase;
Wang, Y, Guo, YR, Liu, K, Yin, Z, Liu, R, Xia, Y, Tan, L, Yang, P, Lee, J-H, Li, X-J, Hawke, D, Zheng, Y, Qian, X, Lyu, J, He, J, Xing, D, Tao, YJ & Lu, Z 2017, Nature, vol. 552, no. 7684, pp. 273-277. DOI: 10.1038/nature25003

C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis;
Yang, J, Liu, Z, Liu, H, He, J, Yang, J, Lin, P, Wang, Q, Du, J, Ma, W, Yin, Z, Davis, E, Orlowski, RZ, Hou, J & Yi, Q 2017, Science signaling, vol. 10, no. 509. DOI: 10.1126/scisignal.aan6282

Repositioning of Drug - New Indications for Marketed Drugs;
Kong, R & Wong, ST 2017, . in Drug Selectivity: An Evolving Concept in Medicinal Chemistry. Wiley, pp. 55-78. DOI: 10.1002/9783527674381.ch3